ConferencePhys Med Biol · December 6, 2021
Objective:To design a deep transfer learning framework for modeling fluence map predictions for stereotactic body radiation therapy (SBRT) of adrenal cancer and similar sites that usually have a small number of cases.Approach:We developed a transfer learni ...
Full textLink to itemCite
ConferenceInternational journal of radiation oncology, biology, physics · November 2021
Purpose/objective(s)Mortality prediction is critical to appropriate cancer care planning. This has become a topic of interest, with machine learning (ML) tools demonstrating accurate binary predictions for mortality at specific time points. There ...
Full textCite
ConferenceInternational journal of radiation oncology, biology, physics · November 2021
Purpose/objective(s)Radiation is increasingly used to treat oligometastatic patients (OM). Following metastasis directed radiation therapy, progression in nearby nodal basins or bones is common. We previously reported clinical outcomes of OM treat ...
Full textCite
ConferenceInternational journal of radiation oncology, biology, physics · November 2021
Purpose/objective(s)Patients undergoing radiotherapy during the COVID-19 pandemic have experienced unique changes to care, including increased use of telehealth for radiotherapy on-treatment visits (OTVs). The objective of this study was to determ ...
Full textCite
ConferenceInternational journal of radiation oncology, biology, physics · November 2021
Purpose/objective(s)Management of HCC without surgical resection or transplantation is poorly defined with no standard. Stereotactic body radiation therapy (SBRT) or hypofractionated image-guided radiotherapy (HIGRT), is an evolving, non-invasive, ...
Full textCite
ConferenceInternational journal of radiation oncology, biology, physics · November 2021
Purpose/objective(s)To date there is no clear standard non-surgical therapeutic option for HCC patients. Ablative radiation therapy (SBRT/HIGRT) is an emerging non-invasive treatment for patients with HCC. However, there is concern about the risk ...
Full textCite
ConferenceJournal of Clinical Oncology · October 1, 2021
277 Background: Oncology telehealth (TH) services may improve access, mitigate care delays, and augment care in select settings. However, logistical and workflow barriers hinder the sustainable adoption of TH services by provider ...
Full textCite
ConferenceJournal of Clinical Oncology · May 20, 2021
1509 Background: SHIELD-RT was a randomized controlled quality improvement study (NCT03775265) that implemented electronic health record-based machine learning (ML) to direct supplemental visits for high risk (HR) patients underg ...
Full textCite
ConferenceJournal of Clinical Oncology · March 1, 2019
33 Background: Synchronous prostate cancer (PC) and rectosigmoid (RS) cancer (RSC) is a challenging clinical situation. Methods: A retrospective review of Duke University and Durham VA charts was performed for men with adenocarci ...
Full textCite
ConferenceTechnology in Cancer Research and Treatment · January 1, 2019
Purpose: To optimize collimator setting to improve dosimetric quality of pancreas volumetric modulated arc therapy plan for stereotactic body radiation therapy. Materials and Methods: Fifty-five volumetric modulated arc therapy cases in stereotactic body r ...
Full textCite
ConferenceJournal of Clinical Oncology · February 1, 2018
741 Background: Adjuvant chemotherapy (AC) following chemoradiation (CRT) and total mesorectal excision (TME) for locoregionally advanced rectal cancer (LARC) is a standard of care in the United States despite limited data. The p ...
Full textCite
ConferenceJournal of Clinical Oncology · February 1, 2017
175 Background: In this prospective study we evaluated whether changes in metabolic tumor parameters on interim flurodeoxyglucose positron emission tomography (FDG-PET) performed during neoadjuvant chemoradiotherapy (CRT) for eso ...
Full textCite
ConferenceJournal of Clinical Oncology · February 1, 2016
657 Background: Prospective randomized trials have demonstrated that neoadjuvant chemoradiation improves local control and results in a higher rate of sphincter-sparing surgery for patients with locally advanced rectal cancer. Ho ...
Full textCite
ConferenceCancer Research · May 1, 2015
AbstractPurpose/Objectives: RT is associated with acute treatment-related complications that can lead to poor quality of life (QOL) and fatigue. Exercise has been shown in other cancer treatment settings to ...
Full textCite
ConferenceCancer Research · May 1, 2015
AbstractBackground: Large randomized controlled trials have shown that hypofractionated whole breast irradiation (HF-WBI) is not inferior to or more toxic than conventionally fractionated whole breast irradi ...
Full textCite
ConferenceCancer Research · May 1, 2015
AbstractBACKGROUND: Breast cancer treatment contributes the greatest proportion of cancer-related health care spending in the United States. Locoregional therapy comprises a significant share of these costs. ...
Full textCite
ConferenceCancer · January 15, 2015
BACKGROUND: The Cancer and Leukemia Group B (CALGB) 9343 randomized phase 3 trial established lumpectomy and adjuvant therapy with tamoxifen alone, rather than both radiotherapy and tamoxifen, as a reasonable treatment course for women aged >70 years with ...
Full textLink to itemCite
ConferenceMed Phys · June 2014
PURPOSE: To investigate the accuracy of 4D-MRI in determining the Internal Target Volume (ITV) used in radiation oncology treatment planning of liver cancers. Cine MRI is used as the standard baseline in establishing the feasibility and accuracy of 4D-MRI ...
Full textLink to itemCite
ConferenceJournal of Clinical Oncology · February 1, 2012
68 Background: EC is commonly managed with concurrent chemoradiotherapy, with or without surgical resection. The optimal combination and dose of agents is the subject of continued investigation. This study examines chemotherapeut ...
Full textCite